glp-1 drug news today 2025 obesity A nice article in The Hindu today highlights the New GLP-1 Guidelines for Type
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 29.The effect of exenatide on thyroid-stimulating hormone and thyroid volume
Yuval Pinto, an obesity medicine physician at Johns Hopkins Medicine, tells Outside
The dose is dependent on how well you tolerate the medication
Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and gradually titrated upward (5 mg, 7.5 mg, 10 mg, 12.5 mg, to a maximum of 15 mg) based on therapeutic response and tolerability
